Similar Durability of Two Single Tablet Regimens, Dolutegravir/Abacavir/Lamivudine and Elvitegravir/Cobicistat/Tenofovir/Emtricitabine: Single Center Experience

Integrase inhibitor is uniquely available as single tablet regimen (STR) in Korea. In this study, the durability until 96 weeks was compared between dolutegravir/abacavir/lamivudine (D/A/L) and elvitegravir/cobicistat/tenofovir/emtricitabine (E/T/E) in treatment naïve human immunodeficiency virus 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Bum Sik, Lee, Jin-Hee, Kim, Gayeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384898/
https://www.ncbi.nlm.nih.gov/pubmed/32715668
http://dx.doi.org/10.3346/jkms.2020.35.e235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384898/
https://www.ncbi.nlm.nih.gov/pubmed/32715668
http://dx.doi.org/10.3346/jkms.2020.35.e235

Ejemplares similares